二氢辣椒碱对肝细胞癌细胞HepG2内apoM表达的影响

doi:10.3969/j.issn.1001-8131.2024.03.002

Abstract
Figure/Table
References
Related Citation (2)

Download: PDF (380 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective Observe the inhibitory effect of dihydrocapsaicin on hepatocellular carcinoma cell（HCC）HepG2 cells and explore the molecular mechanism. Method Divided into blank group and dihydrocapsaidine（100μmol/L,150μmol/L,200μmol/L,250μmol/L）group,Cell counting（CCK-8）was used to detect the activity and quantity of HepG2 cells at different time（24h,48h,72h）and different concentrations of dihydrocapsaicin（100μmol/L,150μmol/L,200μmol/L,250μmol/L）;Using fluorescence quantitative PCR（RT-PCR）of different concentrations of dihydrocapsaicine（150μmol/L,200μmol/L,250μmol/L）on HepG2 cells for 24h,The expression level of intracellular apoM mRCR;After immunosorbent assay（ELISA）,different concentrations（150μmol/L,200μmol/L,250μmol/L）on HepG2 cells,The apoM levels within the cell supernatant.Results Compared to the blank group,Concentration of dihydrocapsaicin at 100μmol/L,No statistically significant differences at each time（24h,48h and 72h）,The remaining concentrations of dihydrocapsaicin（150μmol/L,200μmol/L,250μmol/L）were statistically significant at each time（24h,48h,72h）,It suggests that HepG2 cells have certain time-and concentration-dependent effects on dihydrocapsaicin;Compared to the blank group,In the presence of dihydrocapsaicin at concentrations of 150μmol/L,200μmol/L,and 250μmol/L,The marked downregulation of apoM mRNA expression levels within HepG2 cells in HCC,Moreover,the apoM level in the supernatant of HCC HepG2 cells also decreased（P<0.05）.Conclusion Dihydrocapsaicin has an inhibitory effect on HCC HepG2 cells,and its inhibitory effect may be related to the inhibition of apoM expression in HCC HepG2 cells.

Key words： dihydrocapsaicin hepatocellular carcinoma HepG2 cells apoM cell apoptosis

Received: 04 January 2024

PACS:

R361+.3

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Song Changyue
	Fan Xiaogang
	Liu Hongyuan
	Wang Quan
	Li Chengzhen

Cite this article:

Song Changyue,Fan Xiaogang,Liu Hongyuan, et al. The Effect of Dihydrocyline on Hepatocellular Carcinoma Cell HEPG2 APOM Expression[J]. journal1, 2024, 44(4): 5-7.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2024.03.002 OR http://www.hrbyybjb.org.cn/EN/Y2024/V44/I4/5

[1] 王海燕,赵润根,肖高健.NOD样受体C5对肝癌细胞SMMC-7721凋亡及核转录因子-κB表达的影响[J].解剖学杂志,2022,45(06):537-541.
[2] 邵江娟,金春,彭珣,等.线粒体溶质载体蛋白SLC25 A26诱导肝癌细胞衰老作用及分子机制[J].中国药理学通报,2021,37(2):7-14
[3] 胡海峰,张弦,王水俐.尿毒症血液透析病人并发动脉粥样硬化与血清高迁移率族蛋白B1、中性粒细胞胞外诱捕网的关系[J].安徽医药,2023,27(03):571-575.
[4] Zhou,ManHou,YilinWu,JunLi,et al.miR-93-5p promotes insulin resistance to regulate type 2 diabetes progression in HepG2 cells by targeting HGF[J].Molecular medicine reports,2021,23(5):12-18
[5] 鲁琴,关建华,曾建伟,等.解毒消癥饮通过HIF-1/miR-210调节葡萄糖能量代谢抑制肝癌细胞增殖的生物学机制研究[J].福建中医药,2022,53(11):34-41.
[6] 齐锐,王何斌,李劲,等.肝细胞癌患者血浆BIRC5、ANXA-1抗体水平及在预后判断中的意义[J].国际检验医学杂志,2023,44(03):306-310.
[7] 刘志文,那日苏,马聪.血清PCSK9、vWF和apoM水平在2型糖尿病并发大血管病变中的诊断价值[J].检验医学与临床,2023,20(04):500-505.
[8] 杨自力,张洁,陈娟娟,等.HCV基因型、AFP与P53抗体、ANA在HCV相关肝细胞癌中的相关性[J].热带医学杂志,2021,21(09):1134-1138.
[9] 朱琪,贾海波,季梅丽.冠状动脉粥样硬化性心脏病患者血清前蛋白转化酶枯草溶菌素9、载脂蛋白M与冠状动脉病变程度的关系[J].中国医刊,2021,56(10):1068-1071.
[10] 陈志平,王岚枫,衷敬华,等.miR-573调控载脂蛋白M促进肝细胞迁移的机制研究[J].中国临床药理学杂志,2020,36(20):3260-3263.
[11] 杨云锋,董丽娜,栗凤霞,等.核转运蛋白α2和细胞分裂周期蛋白25同源蛋白C在肝细胞癌组织中的表达及相关性[J].中国医药,2023,18(04):542-545.
[12] 管成剑,于华婧,张小东,等.基于癌症多组学数据库深度解析磷酸甘油激酶1在肝细胞癌中的表达及临床意义[J].解剖学报,2022,53(06):744-753.